Evidence map›Paper›PMID 36359403›Full record

ArticleBiomedicines2022

Mitochondrial Transplantation Moderately Ameliorates Retinal Degeneration in Royal College of Surgeons Rats.

Shih-Fang Wu, Chih-Yao Lin, Rong-Kung Tsai, Yao-Tseng Wen, Feng-Huei Lin, Chia-Yu Chang, Ching-I Shen, Shinn-Zong Lin, Horng-Jyh Harn, Tzyy-Wen Chiou and 3 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Mitochondrial transplantation and transfer: The promising method for diseases.Turkish journal of biology = Turk biyoloji dergisi · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 1 country.

Shih-Fang WuThe Joint Ph.D. Program in Tissue Engineering and Regenerative Medicine, National Health Research Institutes and National Chung Hsing University, Taichung 402, Taiwan.
Chih-Yao LinDepartment of Life Sciences, National Chung Hsing University, Taichung 402, Taiwan.
Rong-Kung TsaiInstitute of Eye Research, Buddhist Tzu Chi Hospital, Hualien 970, Taiwan.ORCID 0000-0001-8760-5739
Yao-Tseng WenInstitute of Eye Research, Buddhist Tzu Chi Hospital, Hualien 970, Taiwan.
Feng-Huei LinInstitute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Miaoli 350, Taiwan.ORCID 0000-0002-2994-6671
Chia-Yu ChangBioinnovation Center, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan.ORCID 0000-0002-3585-5944
Ching-I ShenDuogenic Stem Cells Corporation, Taichung 402, Taiwan.
Shinn-Zong LinBioinnovation Center, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan.ORCID 0000-0002-4601-9933
Horng-Jyh HarnBioinnovation Center, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan.
Tzyy-Wen ChiouDepartment of Life Science and Graduate Institute of Biotechnology, National Dong Hwa University, Hualien 974, Taiwan.
Chin-San LiuVascular and Genomic Center, Changhua Christian Hospital, Changhua 500, Taiwan.
Yan-Ting ChenDepartments of Ophthalmology, Changhua Christian Hospital, Changhua 500, Taiwan.
Hong-Lin SuDepartment of Life Sciences, National Chung Hsing University, Taichung 402, Taiwan.
National Chung Hsing University · TWTzu Chi Foundation · TWBuddhist Tzu Chi General Hospital · TWChanghua Christian Hospital · TWNational Dong Hwa University · TWNational Health Research Institutes · TWStem Cell Technology (Taiwan) · TW

Funding

Ministry of Science and Technology of the People's Republic of China 107-2314-B-005-001-MY3National Chung Hsing University TCVGH-NCHU 109DCA0100017Taichung Veterans General Hospital 108DCA0100011
6 · The paper itself

Abstract

Retinal pigmented epithelial (RPE) cells possess high mitochondria content for energy production, which is required for phagocytosis and vision cycle metabolism. The mitochondrial integrity in RPE cells helps the homeostasis of photoreceptor turnover and prevents retina aging and degeneration. Mitochondrial transplantation benefits the recovery of several acute inflammatory diseases, leading us to investigate the effects of mitochondrial transplantation on retina degeneration. Allogeneic mitochondria were isolated and delivered into the vitreous chamber in the Royal College of Surgeons (RCS) rats, which exhibit inherited and early-onset retina degeneration. The progress of retina degeneration was examined with optical coherence tomography (OCT) and visual evoked potential (VEP) to determine the retina thickness and integrity of afferent electrical signals from affected eyes, respectively. We found that mitochondria engraftment moderately attenuated the degeneration of retinal layers in RCS rats by histological examination. This result was consistent with the OCT measurement of retina thickness around the optic disc. The VEP analysis revealed that the peak one (N1) latency, representing the arriving time of electrical impulse from the retina to cortex, was substantially maintained as the normal value after the mitochondrial transplantation. This result suggests that the intra-vitreous transplanted mitochondria ameliorate the degeneration of photoreceptors in RCS rats and might be potential for clinical application.

Indexed as

macular degenerationmitochondrial transplantationretinal degenerationretinitis pigmentosa

Identifiers

PMID36359403
PMCPMC9687640
OpenAlexW4308695229

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.